Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Pediatr Hematol Oncol ; 38(7): 609-619, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33734010

RESUMEN

Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) is a rare clinical entity. To investigate NLPHL clinical course and treatment a survey was performed within Polish Pediatric Leukaemia/Lymphoma Study Group (PPLLSG) participating centers. A questionnaire was sent to all participating centers and analysis of clinical data was performed. From 2010 to 2019, 19 pediatric patients with confirmed NLPHL were registered in Poland. Median age of patients was 12.2 (5.5 - 17.8) years. NLPHL occurred mainly in males (n = 17). Most of the patients (n = 16) had early stage disease - Stage I (n = 6) and stage II (n = 10). Four of the six patients with stage I disease (I A, n = 5; I B, n = 1) underwent complete primary resection. One of these relapsed and was treated with CVP (cyclophosphamide, vinblastine, prednisone) chemotherapy. Two other patients who were not resected completely received CVP chemotherapy and no relapses were observed. Thirteen patients presented with unresectable disease. Of these, eight received three CVP chemotherapy cycles, and five were treated with other chemotherapy regimens. Three relapses were observed and these patients were further treated with chemotherapy and rituximab. One patient underwent autologous stem cell transplantation (auto-SCT). All patients remain alive. Five-year progression-free survival and overall survival for the entire group of patients was 81.6% and 100%, respectively. NLPHL treatment results are consistent with results noted in other countries. Early stage patients have very good outcomes with surgery and observation or low intensity chemotherapy, but this approach may be insufficient in advanced disease.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Enfermedad de Hodgkin , Adolescente , Niño , Preescolar , Femenino , Enfermedad de Hodgkin/clasificación , Enfermedad de Hodgkin/terapia , Humanos , Linfocitos , Masculino , Polonia , Recurrencia , Trasplante Autólogo
2.
Hematol Oncol ; 37(5): 609-616, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31523837

RESUMEN

Anti-cancer treatment in children can deteriorate gonadal function and affect future fertility. We analyzed the hormonal markers of gonadal function in adolescent leukemia survivors, treated in childhood with different levels of aggressiveness. We analyzed hormone levels in 69 adolescents and young adults, leukemia survivors stratified into standard (SR), intermediate (IR), and high (HR) risk groups, and in 80 healthy controls (38 men) at a similar age. We assessed follicular stimulating hormone (FSH), luteinizing hormone (LH), and inhibin B in the whole group, testosterone in males, and E2 and anti-Müllerian hormone (AMH) in females. Males classified into HR group presented, in comparison to control, higher levels of FSH, LH, lower inhibin B, and normal testosterone, whereas in SR and IR group, the hormonal values were comparable to the control. In females, in all risk groups, the levels of FSH, LH, E2, and inhibin B were comparable with the control, but the mean AMH levels were slightly lowered. We did not observe the effect of prophylactic cranial irradiation (12 or 18 Gy) or the time of treatment (before vs. during puberty) on hormone levels. In females, a positive correlation was found between the time interval after the end of treatment and AMH levels. Male leukemia survivors having undergone more intensive chemotherapy show the symptoms of disturbed spermatogenesis and need to be followed-up in the future. Women, irrespective of the risk group, can develop the signs of preterm ovarian insufficiency. They should be informed about the impact of the treatment on gonadal function.


Asunto(s)
Biomarcadores , Supervivientes de Cáncer , Hormonas Esteroides Gonadales/sangre , Leucemia-Linfoma Linfoblástico de Células Precursoras/sangre , Adolescente , Niño , Preescolar , Terapia Combinada/efectos adversos , Terapia Combinada/métodos , Femenino , Fertilidad , Estudios de Seguimiento , Gónadas/metabolismo , Humanos , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia
3.
Med Wieku Rozwoj ; 7(2): 261-70, 2003.
Artículo en Polaco | MEDLINE | ID: mdl-12878797

RESUMEN

The objective of this study was to estimate the severity of metabolic disorders at onset in children with insulin dependent diabetes mellitus (IDDM). Biochemical results taken at onset of IDDM were analysed in 158 children on their admission. Metabolic acidosis was found in 37.97% of those and ketoacidosis was confirmed in 18.99% children. Mean values of biochemical parameters are similar to those reported in the others European countries. The most severe changes of the acid-base balance parameters were observed in youngest children (1-4 y.o) living in the rural areas (pH, 7.22, HCO3- 10.2 mmol/l, BE - 16.06 mmol/l, p=0.05); this should suggest that those children are watchfully observed and IDDM should be always be considered as a possible cause of any alarming symptoms which occur.


Asunto(s)
Bicarbonatos/sangre , Glucemia/metabolismo , Diabetes Mellitus Tipo 1/fisiopatología , Cetoacidosis Diabética/etiología , Hemoglobina Glucada/metabolismo , Índice de Severidad de la Enfermedad , Adolescente , Factores de Edad , Niño , Preescolar , Diabetes Mellitus Tipo 1/sangre , Cetoacidosis Diabética/sangre , Cetoacidosis Diabética/diagnóstico , Femenino , Humanos , Concentración de Iones de Hidrógeno , Lactante , Masculino , Polonia , Factores de Riesgo , Población Rural/estadística & datos numéricos , Población Urbana/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...